CRCM  Vol.4 No.3 , March 2015
Long Survival (Cure) to Cisplatin/Infusional 5-Flurouracil in Metastatic Squamous Cell Anal Cancer with Extensive Liver and Lung Metastases
Abstract: Background: Metastatic anal Squamous Cell Carcinoma (SCC) is a relatively uncommon malignancy that is usually treated with palliative platinum based chemotherapy. Response rates are modest and complete responses are rare. Case Report: Here we report on a case of advanced SCC with the extensive visceral metastatic disease that has possibly been cured with chemotherapy alone. The patient has received 6 cycles of Cisplatin and 5FU and has remained in complete remission for over 7 years. Conclusion: This is the first report of a case of metastatic anal SCC that has been cured with chemotherapy and highlights the need to remain optimistic when treating patients with “palliative” chemotherapy.
Cite this paper: Haydon, A. , Tay, R. , Mak, G. and Shapiro, J. (2015) Long Survival (Cure) to Cisplatin/Infusional 5-Flurouracil in Metastatic Squamous Cell Anal Cancer with Extensive Liver and Lung Metastases. Case Reports in Clinical Medicine, 4, 73-76. doi: 10.4236/crcm.2015.43017.

[1]   Siegel, R.L., Miller, K.D. and Jemal, A. (2015) Cancer Statistics. CA: A Cancer Journal for Clinicians, 65, 5-29.

[2]   Yhim, H., Lee, R.N., Song, E.K., Kwak, J.Y., Lee, S.T., et al. (2011) The Prognostic Significance of Tumor Human Papillomavirus Status for Patients with Anal Squamous Cell Carcinoma Treated with Combined Chemoradiotherapy. International Journal of Cancer, 129, 1752-1760.

[3]   Jhawer, M., Mani, S., Lefkopoulous, M., Hahn, R.G., Harris, J., et al. (2006) Phase II Study of Mitomycin-C, Adriamycin, Cisplatin (MAP) and Bleomycin-CCNU in Patients with Advanced Cancer of the Anal Canal: An Eastern Cooperative Oncology Group Study E7282. Investigational New Drugs, 24, 447-454.

[4]   Tanum, G. (1993) Treatment of Relapsing Anal Carcinoma. Acta Oncologica, 32, 33-35.

[5]   Ajani, J.A., Carrasco, C.H., Jackson, D.E. and Wallace, S. (1989) Combination of Cisplatin Plus Fluoropyrimidine Chemotherapy Effective against Liver Metastases from Carcinoma of the Anal Canal. The American Journal of Medicine, 87, 221-224.

[6]   Khater, R., Frenay, M., Bourry, J., Milano, G. and Namer, M. (1986) Cisplatin Plus 5-Fluorouracil in the Treatment of Metastatic anal Squamous Cell Carcinoma: A Report of Two Cases. Cancer Treatment Reports, 70, 1345-1346.

[7]   Faivre, C., Rougier, P., Ducreux, M., Mitry, E., Lusinchi, A., et al. (1999) 5-Fluorouracile and Cisplatinum Combination Chemotherapy for Metastatic Squamous-Cell Anal Cancer. Bull Cancer, 86, 861-865.

[8]   Saif, M., Kontny, E., Syrigos, K.N. and Shahrokni, A. (2011) The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series. Journal of Oncology, 125467.

[9]   Lukan, N., Strobel, P., Willer, A., Kripp, M., Dinter, D., et al. (2009) Cetuximab-Based Treatment of Metastatic Anal Cancer: Correlation of Response with KRAS Mutational Status. Oncology, 77, 293-299.

[10]   Evan, T., Mansi, J. and Glees, J. (1993) Response of Metastatic Anal Carcinoma to Single Agent Carboplatin. Clinical Oncology, 5, 57-58.

[11]   Grifaichi, F., Padovani, A., Pomeo, F., Trinca, C., Moscetti, L. and Cortesi, E. (2001) Response of Metastatic Epidermoid Anal Cancer to Single Agent Irinotecan: A Case Report. Tumori, 87, 58-59.